← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Acrigen Biosciences, Inc.
Berkeley, CA
$1,990,291
Total funding
5
Grants
Funding over time
peak $1.3M · FY2020–22$2M$1.5M$1M$500K$0
'20
'21
'22
Funding mix
By agency
NSF$1,225,000 · 2
NIH$765,291 · 3
By mechanism
—$1,225,000 · 2
R43$508,711 · 2
R41$256,580 · 1
Investigators at Acrigen Biosciences, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
SBIR Phase II: Development of a safe gene editing system via CRISPR-Cas and Cas inhibitor co-delivery$1,000,000
· FY2022 · TIP
Enhancing CRISPR-mediated homology-directed repair using anti-CRISPR proteins$256,580
R43 · FY2022 · GM
Development of Safe in Utero Gene Editing Technology in Mice$256,580
R41 · FY2021 · TR
Discovery and applications of CRISPR-Cas inhibitor proteins$252,131
R43 · FY2020 · GM
SBIR Phase I: Development of a safe gene editing system via CRISPR-Cas and Cas inhibitor co-delivery$225,000
· FY2020 · TIP